Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AST-120 in hospital-acquired acute kidney injury
NCT02687841Phase 3Unknown
- Sponsor
- National Taiwan University Hospital
- Start
- Jan 2016
- Primary completion
- Dec 2017
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of activated charcoal in acute kidney injury (AKI) (2 arms), sponsored by National Taiwan University Hospital. Primary endpoint: Total recovery of kidney function at 10 days. Status: unknown.
02
Drugs
activated charcoal
03
Conditions
acute kidney injury (AKI)
Beyond the preview
Go deeper on NCT02687841.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02687841.